Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Ba

Showing results (71-80 of 205) with videos related to

Pageof 21
Sort By:
Theranostics|February 28, 2020
The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancerWu Sun, Jialu Li, Likun Zhou, et al.
Medical Oncology (Northwood, London, England)|November 1, 2013
Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter studyTing Deng, Le Zhang, Xiao-jian Liu, et al.
BMC Cancer|June 2, 2019
Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinomaYuchong Yang, Xuanzhang Huang, Likun Zhou, et al.
The Oncologist|October 3, 2014
S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancreatic cancer: a randomized, open-label, multicenter, phase II studyFeijiao Ge, Nong Xu, Yuxian Bai, et al.
The Journal of Biological Chemistry|February 29, 2012
Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factorShuang-Xia Zhang, Cong Zhu, Yi Ba, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 13, 2018
Platelet to lymphocyte ratio is a predictive marker of prognosis and therapeutic effect of postoperative chemotherapy in non-metastatic esophageal squamous cell carcinomaYuchong Yang, Hao Xu, Likun Zhou, et al.
Scientific Reports|November 19, 2016
Deregulation of the miR-16-KRAS axis promotes colorectal cancerChaoying You, Hongwei Liang, Wu Sun, et al.
Platelets|September 5, 2013
The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancerHaiyan Wang, Jinbiao Gao, Ming Bai, et al.
International Journal of Nanomedicine|April 21, 2020
Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric CancerQiumo Zhang, Haiyang Zhang, Tao Ning, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 17, 2022
Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal CancerQiumo Zhang, Ting Deng, Hongdian Zhang, et al.
Pageof 21

Showing results (71-80 of 205) with videos related to

Sort By:
Pageof 21
Theranostics|February 28, 2020
The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancerWu Sun, Jialu Li, Likun Zhou, et al.
Medical Oncology (Northwood, London, England)|November 1, 2013
Bevacizumab plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as the second-line therapy for patients with metastatic colorectal cancer, a multicenter studyTing Deng, Le Zhang, Xiao-jian Liu, et al.
BMC Cancer|June 2, 2019
Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinomaYuchong Yang, Xuanzhang Huang, Likun Zhou, et al.
The Oncologist|October 3, 2014
S-1 as monotherapy or in combination with leucovorin as second-line treatment in gemcitabine-refractory advanced pancreatic cancer: a randomized, open-label, multicenter, phase II studyFeijiao Ge, Nong Xu, Yuxian Bai, et al.
The Journal of Biological Chemistry|February 29, 2012
Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factorShuang-Xia Zhang, Cong Zhu, Yi Ba, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 13, 2018
Platelet to lymphocyte ratio is a predictive marker of prognosis and therapeutic effect of postoperative chemotherapy in non-metastatic esophageal squamous cell carcinomaYuchong Yang, Hao Xu, Likun Zhou, et al.
Scientific Reports|November 19, 2016
Deregulation of the miR-16-KRAS axis promotes colorectal cancerChaoying You, Hongwei Liang, Wu Sun, et al.
Platelets|September 5, 2013
The pretreatment platelet and plasma fibrinogen level correlate with tumor progression and metastasis in patients with pancreatic cancerHaiyan Wang, Jinbiao Gao, Ming Bai, et al.
International Journal of Nanomedicine|April 21, 2020
Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric CancerQiumo Zhang, Haiyang Zhang, Tao Ning, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 17, 2022
Adipocyte-Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal CancerQiumo Zhang, Ting Deng, Hongdian Zhang, et al.
Pageof 21